Clinical Trials Logo

Clinical Trial Summary

This prospective study will include patients taking or having taken bisphosphonates and needing dental extractions.

The aim of this study is to validate the contribution of PRF (Platelet Rich Fibrin) in tooth extraction sites.

In the test group (PRF) and in the control group (no PRF), we use the same atraumatic extraction protocol associated with the same antibiotic procedure.


Clinical Trial Description

Dental extractions are the main cause of jaw osteonecrosis in patients taking oral or iv bisphosphonates.

This prospective randomized study will include a cohort of 100 patients treated with bisphosphonates (for benign or malignant conditions) and requiring dental extractions (non-retainable teeth for infectious, traumatic or parodontal reasons). 50 patients will benefit of PRF placement in the tooth extraction site (group 1) while 50 patients do not (group 2).

The rest of the procedure will be the same in the 2 arms. In the literature, studies suggest a benefit from a long term antibiotherapy before and after tooth extraction. Extraction procedure should be the least traumatic as possible.

The main objective of our study is to assess, after tooth extraction, the contribution of PRF in the prevention of jaw osteonecrosis induced by bisphosphonates.

A follow-up period of one year after extraction is indicated. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Related Conditions & MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw
  • Osteonecrosis

NCT number NCT02198001
Study type Interventional
Source Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Contact Dorothée L Deneubourg, MD, DDS
Phone 003227645702
Email dorothee.deneubourg@uclouvain.be
Status Recruiting
Phase N/A
Start date January 2014
Completion date January 2017

See also
  Status Clinical Trial Phase
Recruiting NCT06457776 - Medication Related Osteonecrosis of the Jaws (MRONJ) in a Cohort of Patients Treated by Antiresorptive Drugs
Completed NCT01325142 - Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer N/A
Active, not recruiting NCT02932501 - Medication-related Osteonecrosis of the Jaw (MRONJ) Registry